“The advancement of novel therapies like CAR-T in relapsed and refractory pediat...
Scientists have the first direct evidence that the powerful magnetic fields crea...
In a May 15 paper released in the journal Physical Review Letters, Virginia Tech...
The rapidly developing area of pulsed field ablation is gaining momentum all ove...
The U.S. health regulator, FDA, has now allowed Eisai and Biogen to provide data...
Roche, one of the first companies to provide an HPV self-collection option in th...
The FDA has given the go-ahead for Bristol Myers Squibb’s Breyanzi – a cancer ce...
LUNA-18 is under clinical development by Chugai Pharmaceutical and currently in ...
LZ-901 is under clinical development by Beijing Luzhu Biotechnology and currentl...
MRNA-1365 is under clinical development by Moderna and currently in Phase I for ...
LY-3541860 is under clinical development by Eli Lilly and Co and currently in Ph...
TT-01488 is under clinical development by TransThera Sciences (Nanjing) and curr...
Influenza (quadrivalent) vaccine is under clinical development by Pfizer and cur...
Opzelura is under clinical development by Incyte and currently in Phase II for G...
Influenza (quadrivalent) vaccine is under clinical development by Pfizer and cur...
Opzelura is under clinical development by Incyte and currently in Phase II for C...
